title: Sunitinib-associated thrombotic microangiopathy: a significant risk.
authors.affiliation: Haematology Department, Ninewells Hospital, Dundee, UK.
authors.forename: F D
authors.initials: FD
authors.lastname: Buckley
authors.affiliation: Haematology Department, Ninewells Hospital, Dundee, UK.
authors.forename: G
authors.initials: G
authors.lastname: Preston
authors.affiliation: Haematology Department, Ninewells Hospital, Dundee, UK.
authors.forename: D J
authors.initials: DJ
authors.lastname: Meiklejohn
authors.affiliation: Oncology Department, Ninewells Hospital, Dundee, UK.
authors.forename: D
authors.initials: D
authors.lastname: Adamson
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib; D057049:Thrombotic Microangiopathies / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib